Company / Current Liabilities
BioNexus Gene Lab Corp Current Liabilities History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$521.0K
FY2025
5-year range
$521.0K / $2.3M
FY2021-FY2025
Trend
-73.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities has fluctuated over the past 7 years, ranging from $51,574 in FY2019 to $3M in FY2020.
Based on SEC 10-K filings.
$520,957 in FY2025 with a 5-year CAGR of -31.2%.
Improved from $2M to $520,957 over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -36.2%
- 5-Year CAGR
- -31.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -31.2%, indicating a declining trend.
- In FY2025, current liabilities decreased 73.3% year-over-year.
- Peak current liabilities was recorded in FY2020.
- Lowest current liabilities in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 5.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $521.0K | -73.3% |
| FY2024 | $2.0M | +19.6% |
| FY2023 | $1.6M | -18.6% |
| FY2022 | $2.0M | -13.9% |
| FY2021 | $2.3M | -31.0% |
| FY2020 | $3.4M | +6441.3% |
| FY2019 | $51.6K | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026